SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-17-002597
Filing Date
2017-03-20
Accepted
2017-03-20 06:20:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13-d.htm SC 13D 77926
  Complete submission text file 0001493152-17-002597.txt   79485
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Subject) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-84147 | Film No.: 17700037
SIC: 2834 Pharmaceutical Preparations

Mailing Address MONTE PELVOUX 130 FLOOR 3 MEXICO O5 11000
Business Address
Volnie Carlos Fernando Alaman (Filed by) CIK: 0001700629 (see all company filings)

Type: SC 13D